Insider · CIK 0002117686
Kelly Brady
Files at MCRB (Seres Therapeutics, Inc.). First filing May 19, 2026, latest Aug 18, 2026.
Kelly Brady files SEC Form 4 as officer at MCRB (Seres Therapeutics, Inc.). Since May 19, 2026, Kelly Brady has reported 0 open-market buys worth $0 and 2 open-market sells worth $735, the latest filed on Aug 18, 2026.
A track record needs three past buys with six months of prices behind them; Kelly Brady has 0, so none is measured yet.
The newest scored trade: sold $291 of MCRB on Aug 17, 2026, filed Aug 18, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $735.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MCRB: Seres Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Seres Therapeutics, Inc. | $291 64 shares | -1% | +1% from low-84% from high | |
| 15Weak | Seres Therapeutics, Inc. | $444 59 shares | -1% | +8% from low-73% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 15, 2026 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +181 | - | - | 8,743 | Aug 18, 2026 |
| Aug 17, 2026 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -64 | $4.55 | $291 | 8,679 | Aug 18, 2026 |
| Aug 15, 2026 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -90 | $0.00 | $0 | 179 | Aug 18, 2026 |
| Aug 15, 2026 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -91 | $0.00 | $0 | 548 | Aug 18, 2026 |
| Jul 8, 2026 | MCRB Seres Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +18,750 | $0.00 | $0 | 18,750 | Jul 10, 2026 |
| May 15, 2026 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock | +180 | - | - | 8,621 | May 19, 2026 |
| May 18, 2026 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock | -59 | $7.53 | $444 | 8,562 | May 19, 2026 |
| May 15, 2026 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -89 | $0.00 | $0 | 269 | May 19, 2026 |
| May 15, 2026 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -91 | $0.00 | $0 | 639 | May 19, 2026 |
| Mar 4, 2026 | MCRB Seres Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +56,250 | $0.00 | $0 | 56,250 | Mar 11, 2026 |
Questions about Kelly Brady
Answered from the filings on this page, as of the latest one.
Is Kelly Brady buying or selling?
In the last 12 months Kelly Brady reported 0 open-market buys worth $0 and 2 open-market sells worth $735 on SEC Form 4; the latest was sold $291 of MCRB on Aug 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Kelly Brady's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly Brady has 0.
Where does Kelly Brady file Form 4?
Kelly Brady has filed Form 4 at MCRB (Seres Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.